tirzepatide components Explained: The Future of Weight Management Lilly releases Zepbound® (tirzepatide) single-dose

In the Diabetes Therapy journal, researchers from the DZD and Helmholtz Munich provide an overview of these new diabetes and obesity drugs

That said, oral GLP-1 medications for weight loss are advancing quickly, and the research has become much more compelling this year with newer options scheduled to come on the market soon

View full bio

Semaglutide continues to work even after injections stop

In contrast, individuals who received placebo (inactive treatment) injections lost only 9 pounds, or about 4% of their total body weight

This type of hair thinning was potentially developing slowly but was masked by higher oestrogen levels associated with higher body weight